Wedbush lowered the firm’s price target on Keurig Dr Pepper to $35 from $37 on coffee concerns remaining a near-term overhang on the shares, while keeping an Outperform rating on the stock. The firm notes the company delivered a mixed quarter, with revenue missing by 1.2%, and adjusted EPS of 55c coming in a penny ahead of consensus.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on KDP:
- Keurig Dr Pepper price target lowered to $34 from $37 at Barclays
- Keurig Dr Pepper sees FY24 adjusted EPS growth high-single-digit range
- Keurig Dr Pepper reports Q4 adjusted EPS 55c, consensus 54c
- Notable companies reporting before tomorrow’s open
- Keurig Dr Pepper price target lowered to $36 from $38 at UBS
